Mathijs Bunck

Mathijs Bunck

Company: Eli Lilly & Company

Job title: Associate Vice President


The Next Wave of Therapeutics for CKD? Navigating Incretin-Based Therapies & the Kidney 8:00 am

• From pathogenesis to therapeutic intervention: incretin-based drugs and the kidney in type 2 diabetes • Developing incretin-based therapies for the treatment of kidney disease • Investigating the impact of multiple clinical comorbidities including cardiovascular diseases, NASH, and CKDRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.